HB 546 – Maryland
Status: Inactive / DeadYear Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb0546&stab=01&pid=billpage&tab=subject3&ys=2019RS
Altering the definition of “specialty drug” for purposes of certain provisions of law governing access to specialty drugs through certain pharmacies to include a drug designated as a limited distribution drug, a drug that is not available in an oral or self-administered formulation, or a drug that requires special handling above and beyond refrigeration or patient counseling; etc.
Key Issues:
PHARMACEUTICALS
Pharmacy Regulation
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found